Glyburide Tablet shortage
To Be DiscontinuedGlyburide Tablet is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Tablet
Routes
ORAL
Last updated
06/10/2025
Strength variants
- Not specified
Need sourcing help for Glyburide Tablet?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Teva Pharmaceuticals USA, Inc.800-545-8800To Be Discontinued
- Teva Pharmaceuticals USA, Inc.800-545-8800To Be Discontinued
- Teva Pharmaceuticals USA, Inc.800-545-8800To Be Discontinued
- Teva Pharmaceuticals USA, Inc.800-545-8800To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Endocrinology/Metabolism
Dextrose Monohydrate 10% Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/07/2026
Dextrose Monohydrate 5% Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/07/2026
Dextrose Monohydrate 5% Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/07/2026
Dextrose Monohydrate 5% Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/07/2026
Dextrose Monohydrate 5% Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/07/2026
Dextrose Monohydrate 10% Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/07/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.